Education

Biography

Dr. Aliya Iftikhar Sarwar is an Associate Professor of Neurology at Baylor College of Medicine, Houston, Texas, USA and Director of National Parkinson’s Disease, Research, Education, and Clinical Center, at Michael E. DeBakey VAMC, Texas, USA. She is also Board Member and Education Director in HASHOO Foundation. She has given her research support as principal investigator and mentor in funded and unfunded projects. She received faculty excellence award for teaching and evaluation and also for leadership in education in 2014. Her major research interests include Parkinson's disease, neuroprotection, movement disorders and sleep medicine.

Research Interests

• Parkinson's Disease.
• Neuroprotection.
• Movement disorders.
• Sleep medicine

Scientific Activities

Teaching Experience

Professional Activities

Membership For Professional Organizations

Honors and Awards

Publications

1. Calleo J, Amspoker A, Sarwar A, Kunik M, Jankovic J, Marsh L, York M, Stanley M. A pilot study of a cognitive-behavioral treatment for anxiety and depression in patients with Parkinson’s disease. Journal of Geriatric Psychiatry &Neurology 2015 Sep;28(3): 210-7.
2. Rothlind JC, York MK, Carlson K, Luo P, Marks WJ Jr, Weaver FM, Stern M, Follett K, Reda D; CSP-468 Study Group. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun;86(6): 622-9.
3. Mehanna R, Moore S, Hou JG, Sarwar AI, Lai EC Comparing clinical features of young onset, middle onset and late onset Parkinson's disease. Parkinsonism Relat Disord. 2014 May;20(5): 530-4.
4. Patel AJ, Sarwar AI, Jankovic J, Viswanathan A.World Neurosurg. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism.2014 Jul- Aug;82(1-2): 241.e1-4.
5. Rothlind JC, York MK, Carlson K, Luo P, Marks WJ Jr, Weaver FM, Stern M, Follett K, Reda D; CSP-468 Study Group: Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2014 Sep 2.
6. Hou JG, Wu LJ, Moore S, Ward C, York M, Atassi F, Fincher L, Nelson N, Sarwar A, Lai EC. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord 2012 May; 18(4): 377-81.
7. Follett KA, Weaver FM, Stern M, et al and CSP 468 Study Group. Pallidal versus sub thalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010 Jun 3; 362(22): 2077-91.
8. Weaver FM, Follett K, Stern M; CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009 Jan 7; 301(1): 63-73.
9. Vanek Z, Sarwar A. Dystonia - A review of current concepts and their application in Pakistan. Pak J Neurol Sci 2008; 3(1): 20-26.
10. Davis T, MD, Brodsky M, MD, Sarwar AI, MD at al. Consensus Statement on the use of Botulinum Neuro-toxin to treat Spasticity in Adults. P&T. November 2006. Vol 31 (666-682).
11. Sarwar A I, Mosier D R. Hallervorden-Spatz Syndrome, Neurodegeneration with brain iron accumulation. Archive Cases BCM; Neurology. 2000.